Compare TVTX & FBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TVTX | FBNC |
|---|---|---|
| Founded | 2008 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.2B |
| IPO Year | N/A | N/A |
| Metric | TVTX | FBNC |
|---|---|---|
| Price | $33.79 | $53.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 4 |
| Target Price | $37.21 | ★ $56.67 |
| AVG Volume (30 Days) | ★ 1.5M | 190.3K |
| Earning Date | 10-30-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 1.72% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.39 |
| Revenue | ★ $435,826,000.00 | $364,799,000.00 |
| Revenue This Year | $120.36 | $40.17 |
| Revenue Next Year | $37.33 | $12.16 |
| P/E Ratio | ★ N/A | $22.44 |
| Revenue Growth | ★ 114.22 | 0.59 |
| 52 Week Low | $12.91 | $34.50 |
| 52 Week High | $37.50 | $56.45 |
| Indicator | TVTX | FBNC |
|---|---|---|
| Relative Strength Index (RSI) | 47.81 | 61.10 |
| Support Level | $33.84 | $50.79 |
| Resistance Level | $36.24 | $54.03 |
| Average True Range (ATR) | 1.61 | 1.00 |
| MACD | -0.30 | 0.22 |
| Stochastic Oscillator | 7.90 | 68.50 |
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing and investment advisory services.